From Lab to Global Leader
How EIC Health-Tech Innovators can utilise inXso's expertise and EIC ACCESS+ co-funding to achieve international market success.
Supercharge Your Growth with EIC ACCESS+
The EIC ACCESS+ project provides substantial co-funding for deep-tech startups to access essential business services, accelerating your journey to market and investment.
50%
Co-Funding
Receive up to 50% of the costs for services from the EIC Service Catalogue.
€60k
Max Grant
A maximum cumulative grant allowance of €60,000 per beneficiary.
€3.45M
Total Pool
The total financial support available for this call.
Funding Packages Breakdown
The EIC ACCESS+ grant is structured into four distinct packages, each with a specific funding ceiling. This allows you to combine services to meet your unique business needs, from early-stage research to international market entry.
Global Opportunities, Tailored Expertise
inXso provides a strategic advantage in the world's most vital healthcare markets. Discover the benefits of expanding to these key regions with a partner that understands the landscape.
The Americas
Access the World's Largest Healthcare Market
- Navigate the FDA regulatory pathway with expert gap analysis.
- Develop reimbursement strategies for complex payer systems.
- Connect with a vast network of investors and strategic partners.
Europe
Achieve Unified Market Access
- Ensure compliance with EU MDR/IVDR for seamless market entry.
- Utilise diverse national markets for pilot programmes and validation.
- Build cross-border research and commercial collaborations.
Japan
Enter a High-Tech, High-Value Market
- Overcome cultural and business barriers with hands-on guidance.
- Tap into a market with high technology adoption rates.
- Utilise inXso's direct market expertise for strategic matchmaking.
South Korea
Capitalise on a Fast-Growing Innovation Hub
- Navigate a dynamic and competitive landscape.
- Access a world-class clinical trial infrastructure.
- Build partnerships in a leading digital health ecosystem.
A Four-Pillar Approach to Internationalisation
inXso provides a comprehensive framework to guide your venture through the complexities of global expansion, from strategy and execution to regulatory compliance and product design.
1. Formulating a Data-Driven Internationalisation Strategy
Before expanding, a company needs a robust strategy. inXso provides the foundational analysis required to make informed decisions about which markets to enter and how. This includes optimising Go-to-Market (GTM) and commercialisation strategies by analysing distribution channels and costs, and assessing complex healthcare markets like Asia, the US, and the UAE to tailor strategies for the highest potential.
Funding:
Covered by the "Business acceleration" package, with co-funding up to €30,000.
2. Executing Practical Market Entry
A strategy is only as good as its execution. inXso provides hands-on support to turn plans into tangible business opportunities by organising business missions, facilitating matchmaking with key international stakeholders, and assisting in the negotiation of strategic partnership agreements—the most effective vehicle for a startup to gain a foothold in a new country. Our deep expertise in East Asian markets is a concrete example of our capacity to open doors in lucrative but challenging regions.
Funding:
Eligible for the "Business acceleration" package, with co-funding up to €30,000.
3. Navigating Local Regulatory and Reimbursement Hurdles
International success in healthcare hinges on clearing regulatory approval and securing payment pathways. inXso conducts regulatory gap analyses for target markets (e.g., EU MDR, US FDA) to avoid costly delays and develops feasible reimbursement strategies based on local legislation. This ensures providers are incentivised to adopt the new technology, securing vital revenue streams.
Funding:
Can be covered by "Business acceleration" or "Access funds" packages, each up to €30,000.
4. Designing a Global-Ready Product
inXso's support begins early, embedding international considerations into the product itself. Through guidance on cross-cultural and cross-national design, we help innovators create products that are safe, effective, and accepted by diverse user groups. This proactive approach significantly increases a product's global market potential from the outset.
Funding:
Aligns with the "Research package," offering the highest co-funding ceiling of up to €60,000.
Navigating the TRL Gauntlet
inXso's services are mapped to your Technology Readiness Level (TRL), providing the right support at the right time—from experimental proof of concept to a market-proven system.
TRL 3-4: Early Stage
Foundational Strategy
Focus on de-risking development by embedding commercial and regulatory thinking early. Build a solid business case and align technology with a viable product vision.
TRL 5-6: Mid-Stage
Validation & Venture Building
Conduct regulatory gap analysis, establish a Quality Management System (QMS), and formulate a detailed reimbursement strategy to guide clinical validation.
TRL 7-9: Late Stage
Commercial Execution
Execute the GTM strategy, secure international partnerships, and prepare for Series A+ fundraising with expert support in investor readiness and due diligence.
Ready to Accelerate?
Follow these simple steps to apply for EIC ACCESS+ co-funding and start your journey with inXso. Applications are evaluated weekly on a first-come-first-serve basis.
Confirm Eligibility
Ensure your startup is an EIC Awardee (Pathfinder, Transition, Accelerator) or a Seal of Excellence holder from an EU or associated country.
Select inXso
Choose inXso as your service provider from the official EIC Service Catalogue to access our tailored health-tech expertise.
Join the Community
Join the EIC ACCESS+ Community Hub to find and access the official grant application form.
Submit Your Application
Complete and submit the application form via the community hub to secure your spot. Applications are open until 31 May 2026.
Find out more about EIC Catalogue and EIC Access+ Grant
